Madrigal Pharmaceuticals to Release Second-Quarter 2024 Financial Results and Host Webcast on August 7, 2024GlobeNewsWire • 07/24/24
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.The Motley Fool • 06/16/24
Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL CongressGlobeNewsWire • 06/06/24
Madrigal, Akero, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASHInvestors Business Daily • 06/05/24
Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate UpdatesGlobeNewsWire • 05/07/24
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 04/16/24
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking TherapeuticsThe Motley Fool • 04/05/24
Is This Healthcare Stock a Screaming Buy After Scoring a Huge Drug Approval?The Motley Fool • 03/29/24